Ahgeer
Franchise
Media
AGHEER
Clinical Trials Services
Patient Support Services
DM/BS/MW Services
Medical Writing Services
Mobile Nursing Services
Medical Devices Services
Pharmacovigilance Services
Regulatory Services
Careers
English
Français
Contact
Home
About Us
Solutions
Therapeutic Areas
Insights
Achievements
Hepatic-disease Survey
First Name
*
Last Name
*
Degree
*
Position
*
Institution name 1
*
Membership in Professional Organizations
(optional)
Country of Residence
*
Select an Option
Abkhazia
Afghanistan
Åland (Finland)
Albania
Algeria
American Samoa (US)
Andorra
Angola
Anguilla (UK)
Antigua and Barbuda
Argentina
Armenia
Artsakh
Aruba (Netherlands)
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda (UK)
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Brazil
British Virgin Islands (UK)
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands (UK)
Central African Republic
Chad
Channel Islands
Chile
China
Christmas Island (Australia)
Cocos (Keeling) Islands (Australia)
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Côte d'Ivoire
Croatia
Cuba
Curaçao (Netherlands)
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
DR Congo
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Eswatini
Ethiopia
Faeroe Islands
Falkland Islands (UK)
Faroe Islands (Denmark)
Fiji
Finland
France
French Guiana
French Polynesia (France)
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Gibraltar (UK)
Greece
Greenland (Denmark)
Grenada
Guam (US)
Guatemala
Guernsey (UK)
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
Hong Kong (China)
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man (UK)
Italy
Ivory Coast
Jamaica
Japan
Jersey (UK)
Jordan
Kazakhstan
Kenya
Kiribati
Kosovo
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Macao
Macau (China)
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat (UK)
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia (France)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island (Australia)
North Korea
North Macedonia
Northern Cyprus
Northern Mariana Islands (US)
Norway
Oman
Pakistan
Palace
Palau
Palestine
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Islands (UK)
Poland
Portugal
Puerto Rico (US)
Qatar
Réunion
Romania
Russia
Rwanda
Saint Barthélemy (France)
Saint Helena Ascension and Tristan da Cunha (UK)
Saint Kitts and Nevis
Saint Lucia
Saint Martin (France)
Saint Pierre and Miquelon (France)
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome & Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten (Netherlands)
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Korea
South Ossetia
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
The Bahamas
Timor-Leste
Togo
Tokelau (NZ)
Tonga
Transnistria
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands (UK)
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
US Virgin Islands (US)
Uzbekistan
Vanuatu
Vatican City
Venezuela
Vietnam
Wallis and Futuna (France)
Western Sahara
Yemen
Zambia
Zimbabwe
Personal Email
*
Country code
(optional)
Select an Option
Afghanistan (+93)
Åland (+358 18)
Albania (+355)
Algeria (+213)
American Samoa (+1 684)
Andorra (+376)
Angola (+244)
Anguilla (+1 264)
Antigua and Barbuda (+1 268)
Argentina (+54)
Armenia (+374)
Aruba (+297)
Ascension (+247)
Australia (+61)
Australian Antarctic Territory (+672 1)
Australian External Territories (+672)
Austria (+43)
Azerbaijan (+994)
Bahamas (+1 242)
Bahrain (+973)
Bangladesh (+880)
Barbados (+1 246)
Barbuda (+1 268)
Belarus (+375)
Belgium (+32)
Belize (+501)
Benin (+229)
Bermuda (+1 441)
Bhutan (+975)
Bolivia (+591)
Bonaire (+599 7)
Bosnia and Herzegovina (+387)
Botswana (+267)
Brazil (+55)
British Indian Ocean Territory (+246)
British Virgin Islands (+1 284)
Brunei Darussalam (+673)
Bulgaria (+359)
Burkina Faso (+226)
Burundi (+257)
Cape Verde (+238)
Cambodia (+855)
Cameroon (+237)
Canada (+1)
Caribbean Netherlands (+599 3)
Caribbean Netherlands (+599 4)
Caribbean Netherlands (+599 7)
Cayman Islands (+1 345)
Central African Republic (+236)
Chad (+235)
Chatham Island, New Zealand (+64)
Chile (+56)
China (+86)
Christmas Island (+61 89164)
Cocos (Keeling) Islands (+61 89162)
Colombia (+57)
Comoros (+269)
Congo (+242)
Congo, Democratic Republic of the (+243)
Cook Islands (+682)
Costa Rica (+506)
Ivory Coast (Côte d'Ivoire) (+225)
Croatia (+385)
Cuba (+53)
Curaçao (+599 9)
Cyprus (+357)
Czech Republic (+420)
Denmark (+45)
Diego Garcia (+246)
Djibouti (+253)
Dominica (+1 767)
Dominican Republic (+1 809)
Dominican Republic (+1 829)
Dominican Republic (+1 849)
Easter Island (+56)
Ecuador (+593)
Egypt (+20)
El Salvador (+503)
Equatorial Guinea (+240)
Eritrea (+291)
Estonia (+372)
Eswatini (+268)
Ethiopia (+251)
Falkland Islands (+500)
Faroe Islands (+298)
Fiji (+679)
Finland (+358)
France (+33)
French Antilles (+596)
French Guiana (+594)
French Polynesia (+689)
Gabon (+241)
Gambia (+220)
Georgia (+995)
Germany (+49)
Ghana (+233)
Gibraltar (+350)
Greece (+30)
Greenland (+299)
Grenada (+1 473)
Guadeloupe (+590)
Guam (+1 671)
Guatemala (+502)
Guernsey (+44 1481)
Guernsey (+44 7781)
Guernsey (+44 7839)
Guernsey (+44 7911)
Guinea (+224)
Guinea-Bissau (+245)
Guyana (+592)
Haiti (+509)
Honduras (+504)
Hong Kong (+852)
Hungary (+36)
Iceland (+354)
India (+91)
Indonesia (+62)
Iran (+98)
Iraq (+964)
Ireland (+353)
Italy (+39)
Jamaica (+1658)
Jamaica (+1 876)
Jan Mayen (+47 79)
Japan (+81)
Jersey (+44 1534)
Jordan (+962)
Kazakhstan (+7 6)
Kazakhstan (+7 7)
Kenya (+254)
Kiribati (+686)
Korea, North (+850)
Korea, South (+82)
Kosovo (+383)
Kuwait (+965)
Kyrgyzstan (+996)
Laos (+856)
Latvia (+371)
Lebanon (+961)
Lesotho (+266)
Liberia (+231)
Libya (+218)
Liechtenstein (+423)
Lithuania (+370)
Luxembourg (+352)
Macau (+853)
Madagascar (+261)
Malawi (+265)
Malaysia (+60)
Maldives (+960)
Mali (+223)
Malta (+356)
Marshall Islands (+692)
Martinique (+596)
Mauritania (+222)
Mauritius (+230)
Mayotte (+262 269)
Mayotte (+262 639)
Mexico (+52)
Micronesia, Federated States of (+691)
Midway Island, USA (+1 808)
Moldova (+373)
Monaco (+377)
Mongolia (+976)
Montenegro (+382)
Montserrat (+1 664)
Morocco (+212)
Mozambique (+258)
Myanmar (+95)
Artsakh (+374 47)
Artsakh (+374 97)
Namibia (+264)
Nauru (+674)
Nepal (+977)
Netherlands (+31)
Nevis (+1 869)
New Caledonia (+687)
New Zealand (+64)
Nicaragua (+505)
Niger (+227)
Nigeria (+234)
Niue (+683)
Norfolk Island (+672 3)
North Macedonia (+389)
Northern Cyprus (+90 392)
Northern Ireland (+44 28)
Northern Mariana Islands (+1 670)
Norway (+47)
Oman (+968)
Pakistan (+92)
Palau (+680)
Palestine, State of (+970)
Panama (+507)
Papua New Guinea (+675)
Paraguay (+595)
Peru (+51)
Philippines (+63)
Pitcairn Islands (+64)
Poland (+48)
Portugal (+351)
Puerto Rico (+1 787)
Puerto Rico (+ 1 939)
Qatar (+974)
Réunion (+262)
Romania (+40)
Russia (+7)
Rwanda (+250)
Saba (+599 4)
Saint Barthélemy (+590)
Saint Helena (+290)
Saint Kitts and Nevis (+1 869)
Saint Lucia (+1 758)
Saint Martin (France) (+590)
Saint Pierre and Miquelon (+508)
Saint Vincent and the Grenadines (+1 784)
Samoa (+685)
San Marino (+378)
São Tomé and Príncipe (+239)
Saudi Arabia (+966)
Senegal (+221)
Serbia (+381)
Seychelles (+248)
Sierra Leone (+232)
Singapore (+65)
Sint Eustatius (+599 3)
Sint Maarten (Netherlands) (+1 721)
Slovakia (+421)
Slovenia (+386)
Solomon Islands (+677)
Somalia (+252)
South Africa (+27)
South Georgia and the South Sandwich Islands (+500)
South Ossetia (+995 34)
South Sudan (+211)
Spain (+34)
Sri Lanka (+94)
Sudan (+249)
Suriname (+597)
Svalbard (+47 79)
Sweden (+46)
Switzerland (+41)
Syria (+963)
Taiwan (+886)
Tajikistan (+992)
Tanzania (+255)
Telecommunications for Disaster Relief by OCHA (+888)
Thailand (+66)
Thuraya (Mobile Satellite service) (+882 16)
East Timor (Timor-Leste) (+670)
Togo (+228)
Tokelau (+690)
Tonga (+676)
Transnistria (+3732)
Transnistria (+373 5)
Trinidad and Tobago (+1 868)
Tristan da Cunha (+290 8)
Tunisia (+216)
Turkey (+90)
Turkmenistan (+993)
Turks and Caicos Islands (+1 649)
Tuvalu (+688)
Uganda (+256)
Ukraine (+380)
United Arab Emirates (+971)
United Kingdom (+44)
United States (+1)
Universal Personal Telecommunications (UPT) (+878)
Uruguay (+598)
US Virgin Islands (+1 340)
Uzbekistan (+998)
Vanuatu (+678)
Vatican City State (Holy See) (+39 06 698, assigned 379)
Venezuela (+58)
Vietnam (+84)
Wake Island, USA (+1 808)
Wallis and Futuna (+681)
Yemen (+967)
Zambia (+260)
Zanzibar (+255 24)
Zimbabwe (+263)
Personal Phone
(optional)
Upload CV & Publications & Relevant Certifications
Attachment 1
Please provide an approximate breakdown of the number of patients treated in your department for specific types of Hepatic diseases in the past 12 months (last year)?
*
Number of patients in the last year of Hepatic and Gastric Diseases 1
*
Select Type
Chronic Liver Disease
Chronic Hepatic Failure
Portal Hypertensive Gastropathy
Chronic Viral Hepatitis B
Malignant Neoplasm of Liver cell carcinoma
Ascites
Hepatic Failure
Gastroesophageal Reflux Disease
Cholecystitis
Chronic Viral Hepatitis C
Nonalcoholic Steatohepatitis (NASH)
Dyspepsia
Gastroenteritis and Colitis
Hepatitis D
Hepatitis A
Alcoholic Cirrhosis
Non-alcoholic Cirrhosis
Non-Alcoholic Fatty Liver Disease (NAFLD)
Alcoholic Fatty Liver Disease (AFLD)
Liver Fibrosis
Cholangiocarcinoma
Autoimmune Hepatitis
Hemochromatosis
Wilson's Disease
Primary Biliary Cirrhosis (PBC)
Primary Sclerosing Cholangitis (PSC)
Other
Select number patients in the last year
1-50
51-100
> 100
Have you published or contributed in any research papers or scientific literature in the field of hepatic diseases?
*
Yes
No
Was it conducted in a clinical research unit with an IRB Committee?
*
Yes
No
What type of IRB/Ethics Committee can you utilize?
*
Select an Option
Local
Central
Both
Please indicate your general Hepatic clinical trial experience, by phase, over the last year?
(optional)
Phase 1
Phase 2
Phase 3
Post-Marketing
Investigator sponsored research ES
What challenges have you encountered when conducting clinical trials for hepatic diseases, and how did you address them?
(optional)
Are you trained on ICG-GCP Guidelines?
*
Yes
No
How do you stay updated on the latest advancements and treatments in hepatic disease research?
*
Regularly attending medical conferences and seminars
Reading scientific journals and publications
Collaborating with other experts in the field
Engaging in continuous medical education
Other
Other
Would you be interested in being contacted for clinical trial participation in hepatic disease?
*
Yes
No
Next